| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 34 | 2020 | 681 | 3.550 |
Why?
|
| Porins | 19 | 2010 | 42 | 2.710 |
Why?
|
| Mitochondrial Diseases | 17 | 2017 | 133 | 2.480 |
Why?
|
| Voltage-Dependent Anion Channels | 23 | 2011 | 31 | 2.010 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 18 | 2020 | 23 | 2.000 |
Why?
|
| DNA, Mitochondrial | 17 | 2018 | 211 | 1.660 |
Why?
|
| Mutation | 44 | 2022 | 5846 | 1.380 |
Why?
|
| RNA, Transfer | 2 | 2020 | 72 | 1.320 |
Why?
|
| Mitochondrial Proteins | 10 | 2017 | 227 | 1.200 |
Why?
|
| Glycogen Storage Disease Type IV | 3 | 2015 | 5 | 0.890 |
Why?
|
| Chromosome Deletion | 11 | 2014 | 647 | 0.880 |
Why?
|
| MELAS Syndrome | 5 | 2016 | 33 | 0.870 |
Why?
|
| Voltage-Dependent Anion Channel 2 | 13 | 2016 | 17 | 0.870 |
Why?
|
| Ion Channels | 8 | 2003 | 190 | 0.830 |
Why?
|
| Intellectual Disability | 12 | 2023 | 1056 | 0.820 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 3153 | 0.800 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 2 | 2012 | 4 | 0.770 |
Why?
|
| Abnormalities, Multiple | 13 | 2014 | 960 | 0.760 |
Why?
|
| Gene Deletion | 8 | 2020 | 789 | 0.740 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 7 | 2019 | 100 | 0.670 |
Why?
|
| Membrane Proteins | 9 | 2012 | 1531 | 0.640 |
Why?
|
| Neurodevelopmental Disorders | 5 | 2023 | 502 | 0.620 |
Why?
|
| Mitochondria, Muscle | 3 | 2006 | 34 | 0.620 |
Why?
|
| Evolution, Molecular | 5 | 2008 | 669 | 0.610 |
Why?
|
| Sequence Analysis, DNA | 14 | 2015 | 1757 | 0.580 |
Why?
|
| Genomics | 6 | 2024 | 1502 | 0.570 |
Why?
|
| Humans | 139 | 2024 | 124906 | 0.560 |
Why?
|
| Glycerol Kinase | 5 | 2005 | 19 | 0.540 |
Why?
|
| Point Mutation | 3 | 2018 | 347 | 0.530 |
Why?
|
| Infant | 50 | 2020 | 12477 | 0.530 |
Why?
|
| Animals | 62 | 2022 | 34057 | 0.530 |
Why?
|
| Fibroblasts | 12 | 2024 | 882 | 0.530 |
Why?
|
| Phenotype | 28 | 2023 | 4254 | 0.520 |
Why?
|
| Noonan Syndrome | 3 | 2018 | 30 | 0.520 |
Why?
|
| Mice | 49 | 2020 | 17583 | 0.520 |
Why?
|
| Glycogen Storage Disease | 3 | 2015 | 9 | 0.490 |
Why?
|
| Genome | 3 | 2022 | 472 | 0.480 |
Why?
|
| Base Sequence | 28 | 2017 | 3090 | 0.480 |
Why?
|
| Chromosome Mapping | 12 | 2014 | 1079 | 0.470 |
Why?
|
| RNA, Transfer, Leu | 1 | 2014 | 6 | 0.460 |
Why?
|
| Molecular Sequence Data | 27 | 2014 | 3877 | 0.460 |
Why?
|
| Cell Membrane Permeability | 6 | 2010 | 74 | 0.460 |
Why?
|
| Genes, Mitochondrial | 1 | 2014 | 17 | 0.460 |
Why?
|
| Nitric Oxide | 6 | 2016 | 445 | 0.450 |
Why?
|
| Electron Transport | 7 | 2020 | 53 | 0.450 |
Why?
|
| Male | 85 | 2024 | 61395 | 0.450 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2012 | 155 | 0.450 |
Why?
|
| Lysosomal Storage Diseases | 2 | 2024 | 36 | 0.450 |
Why?
|
| Drosophila melanogaster | 3 | 2010 | 770 | 0.450 |
Why?
|
| X Chromosome | 5 | 1999 | 338 | 0.440 |
Why?
|
| Apoptosis | 9 | 2016 | 1795 | 0.440 |
Why?
|
| Exome | 4 | 2018 | 1033 | 0.440 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 8 | 2010 | 61 | 0.430 |
Why?
|
| Kidney | 2 | 2020 | 1356 | 0.420 |
Why?
|
| Infertility, Male | 2 | 2010 | 262 | 0.420 |
Why?
|
| Protein Isoforms | 12 | 2018 | 404 | 0.420 |
Why?
|
| Female | 80 | 2024 | 66678 | 0.420 |
Why?
|
| RNA Helicases | 1 | 2013 | 63 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2011 | 140 | 0.410 |
Why?
|
| Arginine | 5 | 2016 | 332 | 0.410 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 633 | 0.410 |
Why?
|
| Metabolism, Inborn Errors | 3 | 2019 | 116 | 0.400 |
Why?
|
| Transcription Factors | 7 | 2023 | 2582 | 0.390 |
Why?
|
| Citrulline | 4 | 2016 | 107 | 0.390 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2012 | 9 | 0.390 |
Why?
|
| Citrullinemia | 1 | 2012 | 15 | 0.390 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2021 | 443 | 0.390 |
Why?
|
| Seizures | 5 | 2023 | 874 | 0.380 |
Why?
|
| Disease Models, Animal | 7 | 2017 | 4353 | 0.380 |
Why?
|
| Exons | 6 | 2015 | 797 | 0.380 |
Why?
|
| Genetic Variation | 7 | 2018 | 1497 | 0.360 |
Why?
|
| Child, Preschool | 42 | 2021 | 14019 | 0.360 |
Why?
|
| Growth Disorders | 3 | 2020 | 209 | 0.360 |
Why?
|
| Infant, Newborn | 25 | 2021 | 8199 | 0.360 |
Why?
|
| Argininosuccinate Lyase | 3 | 2012 | 57 | 0.350 |
Why?
|
| Developmental Disabilities | 9 | 2023 | 712 | 0.350 |
Why?
|
| Genetic Testing | 7 | 2024 | 1002 | 0.350 |
Why?
|
| Alternative Splicing | 5 | 2000 | 348 | 0.350 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2009 | 22 | 0.340 |
Why?
|
| Models, Genetic | 2 | 2011 | 759 | 0.340 |
Why?
|
| Child | 46 | 2023 | 24410 | 0.340 |
Why?
|
| Cloaca | 1 | 2010 | 15 | 0.340 |
Why?
|
| Anus, Imperforate | 1 | 2010 | 20 | 0.340 |
Why?
|
| Nervous System Diseases | 4 | 2024 | 375 | 0.340 |
Why?
|
| Acidosis, Lactic | 4 | 2018 | 30 | 0.330 |
Why?
|
| Pedigree | 13 | 2018 | 1605 | 0.330 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2016 | 71 | 0.330 |
Why?
|
| Mitochondrial Membranes | 7 | 2016 | 30 | 0.330 |
Why?
|
| Pathology, Molecular | 1 | 2010 | 58 | 0.330 |
Why?
|
| Glucose | 1 | 2014 | 876 | 0.330 |
Why?
|
| Adenosine Triphosphate | 4 | 2020 | 282 | 0.330 |
Why?
|
| Peptide Termination Factors | 6 | 1990 | 16 | 0.330 |
Why?
|
| Adenosine Diphosphate | 3 | 2010 | 57 | 0.330 |
Why?
|
| Hernia, Umbilical | 1 | 2010 | 42 | 0.320 |
Why?
|
| Mutation, Missense | 10 | 2017 | 875 | 0.320 |
Why?
|
| Aorta | 2 | 2011 | 541 | 0.320 |
Why?
|
| Intracellular Membranes | 4 | 2008 | 63 | 0.320 |
Why?
|
| Spine | 1 | 2010 | 142 | 0.320 |
Why?
|
| Amino Acid Sequence | 18 | 2018 | 2704 | 0.310 |
Why?
|
| Mitochondrial Dynamics | 2 | 2020 | 45 | 0.310 |
Why?
|
| Microcephaly | 4 | 2020 | 330 | 0.290 |
Why?
|
| Body Patterning | 3 | 2008 | 122 | 0.290 |
Why?
|
| Muscle, Skeletal | 8 | 2013 | 947 | 0.290 |
Why?
|
| Genome, Human | 3 | 2018 | 1273 | 0.280 |
Why?
|
| Autism Spectrum Disorder | 2 | 2023 | 390 | 0.280 |
Why?
|
| Drosophila Proteins | 3 | 2008 | 714 | 0.280 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 778 | 0.280 |
Why?
|
| Adolescent | 34 | 2023 | 19343 | 0.270 |
Why?
|
| Hexokinase | 1 | 2006 | 21 | 0.270 |
Why?
|
| Liver Failure | 1 | 2007 | 89 | 0.270 |
Why?
|
| Galactosemias | 1 | 2006 | 14 | 0.270 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2006 | 13 | 0.270 |
Why?
|
| Galactose | 1 | 2006 | 54 | 0.260 |
Why?
|
| Movement Disorders | 2 | 2023 | 222 | 0.260 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2006 | 36 | 0.260 |
Why?
|
| Chromosome Aberrations | 5 | 2009 | 616 | 0.260 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 872 | 0.260 |
Why?
|
| DNA Mutational Analysis | 7 | 2021 | 794 | 0.260 |
Why?
|
| DNA-Binding Proteins | 6 | 2023 | 2043 | 0.250 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 443 | 0.250 |
Why?
|
| Mitochondrial Encephalomyopathies | 2 | 2018 | 27 | 0.250 |
Why?
|
| Neurons | 4 | 2024 | 1922 | 0.250 |
Why?
|
| Succinate-CoA Ligases | 2 | 2016 | 4 | 0.240 |
Why?
|
| Brain | 5 | 2015 | 2994 | 0.240 |
Why?
|
| F-Box Proteins | 2 | 2017 | 34 | 0.240 |
Why?
|
| Heterozygote | 8 | 2020 | 671 | 0.240 |
Why?
|
| Databases, Genetic | 4 | 2024 | 473 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2002 | 72 | 0.240 |
Why?
|
| Adult | 26 | 2023 | 29576 | 0.240 |
Why?
|
| DNA, Complementary | 10 | 2005 | 461 | 0.240 |
Why?
|
| Syndrome | 12 | 2022 | 1120 | 0.240 |
Why?
|
| Glutarates | 4 | 2004 | 37 | 0.230 |
Why?
|
| Megalencephaly | 2 | 2023 | 57 | 0.230 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2017 | 366 | 0.230 |
Why?
|
| Homozygote | 5 | 2013 | 548 | 0.230 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2006 | 170 | 0.230 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2018 | 73 | 0.220 |
Why?
|
| Leigh Disease | 2 | 2012 | 24 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 358 | 0.220 |
Why?
|
| Epilepsy | 5 | 2023 | 871 | 0.220 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2014 | 153 | 0.220 |
Why?
|
| Muscular Diseases | 2 | 2015 | 104 | 0.220 |
Why?
|
| Gene Duplication | 4 | 2014 | 362 | 0.220 |
Why?
|
| Mice, Knockout | 10 | 2013 | 3719 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 64 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 882 | 0.210 |
Why?
|
| Neuronal Plasticity | 2 | 2004 | 272 | 0.210 |
Why?
|
| RNA, Messenger | 5 | 2020 | 2815 | 0.210 |
Why?
|
| Argininosuccinic Acid | 1 | 2003 | 7 | 0.210 |
Why?
|
| Situs Inversus | 3 | 2002 | 26 | 0.210 |
Why?
|
| Introns | 2 | 2021 | 299 | 0.210 |
Why?
|
| Blotting, Western | 6 | 2017 | 1101 | 0.210 |
Why?
|
| Alleles | 11 | 2021 | 1614 | 0.200 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 4 | 2010 | 14 | 0.200 |
Why?
|
| Genotype | 11 | 2019 | 2557 | 0.200 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 292 | 0.200 |
Why?
|
| Genes, Recessive | 5 | 2016 | 185 | 0.200 |
Why?
|
| Transcription, Genetic | 6 | 2017 | 1697 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 994 | 0.200 |
Why?
|
| Muscle Hypotonia | 4 | 2023 | 187 | 0.200 |
Why?
|
| Kartagener Syndrome | 2 | 2002 | 14 | 0.200 |
Why?
|
| Histones | 3 | 2022 | 525 | 0.190 |
Why?
|
| Osteopetrosis | 1 | 2001 | 14 | 0.190 |
Why?
|
| Fractures, Spontaneous | 1 | 2001 | 18 | 0.190 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 162 | 0.190 |
Why?
|
| Genetic Counseling | 2 | 2020 | 220 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 370 | 0.190 |
Why?
|
| Microscopy, Electron | 4 | 2010 | 394 | 0.180 |
Why?
|
| Aniridia | 1 | 2021 | 12 | 0.180 |
Why?
|
| Glycogen | 2 | 2011 | 63 | 0.180 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2014 | 762 | 0.180 |
Why?
|
| Skin | 3 | 2021 | 521 | 0.180 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 34 | 0.180 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2021 | 10 | 0.180 |
Why?
|
| Myocardium | 5 | 2017 | 998 | 0.180 |
Why?
|
| Transition to Adult Care | 1 | 2023 | 119 | 0.180 |
Why?
|
| Electron Transport Complex IV | 4 | 2012 | 38 | 0.180 |
Why?
|
| Sperm Motility | 1 | 2001 | 94 | 0.180 |
Why?
|
| Neonatal Screening | 3 | 2021 | 184 | 0.180 |
Why?
|
| Young Adult | 15 | 2020 | 9051 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 66 | 0.170 |
Why?
|
| Kidney Cortex | 1 | 2020 | 20 | 0.170 |
Why?
|
| Cell Respiration | 1 | 2020 | 23 | 0.170 |
Why?
|
| Proton-Translocating ATPases | 1 | 2020 | 17 | 0.170 |
Why?
|
| Hydrocephalus | 1 | 2023 | 243 | 0.170 |
Why?
|
| Dilatation, Pathologic | 2 | 2011 | 93 | 0.170 |
Why?
|
| Dietary Supplements | 2 | 2016 | 476 | 0.170 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 240 | 0.170 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 36 | 0.170 |
Why?
|
| Propionic Acidemia | 1 | 2019 | 10 | 0.170 |
Why?
|
| DNA Helicases | 3 | 2013 | 231 | 0.170 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 126 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2011 | 103 | 0.160 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 2 | 1996 | 2 | 0.160 |
Why?
|
| Heart Defects, Congenital | 6 | 2011 | 1815 | 0.160 |
Why?
|
| Retroelements | 1 | 1999 | 40 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 200 | 0.160 |
Why?
|
| Hippocampus | 3 | 2017 | 825 | 0.160 |
Why?
|
| Mitochondrial Myopathies | 2 | 2018 | 28 | 0.160 |
Why?
|
| Cilia | 1 | 2020 | 74 | 0.160 |
Why?
|
| Dehydrocholesterols | 1 | 1999 | 1 | 0.160 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 1999 | 8 | 0.160 |
Why?
|
| Chromosomes, Human, X | 3 | 2010 | 157 | 0.160 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2018 | 12 | 0.160 |
Why?
|
| Codon | 3 | 1990 | 97 | 0.150 |
Why?
|
| Ion Channel Gating | 5 | 2006 | 122 | 0.150 |
Why?
|
| Learning | 1 | 2002 | 360 | 0.150 |
Why?
|
| Nucleotide Transport Proteins | 1 | 2018 | 2 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 120 | 0.150 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2011 | 62 | 0.150 |
Why?
|
| Ribosomes | 2 | 1990 | 137 | 0.150 |
Why?
|
| Genomic Imprinting | 5 | 2003 | 124 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2019 | 161 | 0.150 |
Why?
|
| Mitochondria, Liver | 3 | 2007 | 30 | 0.150 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2019 | 77 | 0.150 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 106 | 0.150 |
Why?
|
| Pseudohypoparathyroidism | 1 | 1997 | 7 | 0.140 |
Why?
|
| Hypotrichosis | 1 | 1997 | 8 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 241 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2020 | 1507 | 0.140 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2018 | 67 | 0.140 |
Why?
|
| Chromatin | 2 | 2019 | 550 | 0.140 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2014 | 572 | 0.140 |
Why?
|
| Genetics, Medical | 1 | 2018 | 118 | 0.140 |
Why?
|
| YY1 Transcription Factor | 1 | 2017 | 12 | 0.140 |
Why?
|
| Genes | 2 | 1997 | 445 | 0.140 |
Why?
|
| Anodontia | 1 | 1997 | 30 | 0.140 |
Why?
|
| Homocystinuria | 1 | 2017 | 23 | 0.140 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2017 | 23 | 0.140 |
Why?
|
| Language Development Disorders | 3 | 2014 | 174 | 0.140 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 41 | 0.140 |
Why?
|
| Heart Ventricles | 4 | 2017 | 763 | 0.140 |
Why?
|
| Ectodermal Dysplasia | 1 | 1997 | 45 | 0.140 |
Why?
|
| DNA Copy Number Variations | 3 | 2017 | 949 | 0.140 |
Why?
|
| Calcium | 4 | 2018 | 1099 | 0.140 |
Why?
|
| Ischemia | 1 | 2020 | 357 | 0.130 |
Why?
|
| Disease Management | 2 | 2017 | 525 | 0.130 |
Why?
|
| Siblings | 2 | 2018 | 197 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2011 | 78 | 0.130 |
Why?
|
| Biomarkers | 5 | 2019 | 3069 | 0.130 |
Why?
|
| Escherichia coli Proteins | 3 | 1988 | 305 | 0.130 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2007 | 23 | 0.130 |
Why?
|
| Embryo, Mammalian | 4 | 2013 | 453 | 0.130 |
Why?
|
| Argininosuccinic Aciduria | 2 | 2009 | 47 | 0.130 |
Why?
|
| Dichloroacetic Acid | 1 | 1996 | 11 | 0.130 |
Why?
|
| Glycolates | 1 | 1996 | 12 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2018 | 254 | 0.130 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2015 | 2 | 0.130 |
Why?
|
| Cells, Cultured | 13 | 2010 | 3039 | 0.130 |
Why?
|
| Transaminases | 1 | 1996 | 32 | 0.130 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 81 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 254 | 0.120 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2015 | 14 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 258 | 0.120 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2015 | 20 | 0.120 |
Why?
|
| Testis | 4 | 2010 | 407 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 262 | 0.120 |
Why?
|
| Status Epilepticus | 1 | 2017 | 144 | 0.120 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 5165 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 435 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 1996 | 157 | 0.120 |
Why?
|
| 4-Aminobutyrate Transaminase | 1 | 2015 | 7 | 0.120 |
Why?
|
| Nucleosides | 1 | 2015 | 17 | 0.120 |
Why?
|
| Muscle, Striated | 2 | 2015 | 10 | 0.120 |
Why?
|
| Metabolomics | 1 | 2019 | 422 | 0.120 |
Why?
|
| Protein Biosynthesis | 3 | 1987 | 663 | 0.120 |
Why?
|
| Coloboma | 2 | 2005 | 45 | 0.120 |
Why?
|
| Fatty Acids | 1 | 1997 | 347 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2015 | 173 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 306 | 0.120 |
Why?
|
| Fungal Proteins | 2 | 2004 | 129 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2012 | 118 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 1997 | 382 | 0.120 |
Why?
|
| Cell Line | 6 | 2005 | 2746 | 0.120 |
Why?
|
| Sequence Analysis, Protein | 2 | 2005 | 49 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 294 | 0.120 |
Why?
|
| Cardiomyopathies | 3 | 2004 | 491 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 154 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2014 | 104 | 0.110 |
Why?
|
| Mosaicism | 1 | 2016 | 240 | 0.110 |
Why?
|
| Epilepsies, Myoclonic | 1 | 1994 | 24 | 0.110 |
Why?
|
| Brain Diseases, Metabolic | 1 | 1994 | 12 | 0.110 |
Why?
|
| Receptors, GABA | 1 | 2014 | 17 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2006 | 461 | 0.110 |
Why?
|
| Karyotyping | 3 | 2011 | 328 | 0.110 |
Why?
|
| Proteins | 5 | 2003 | 1036 | 0.110 |
Why?
|
| Gluconeogenesis | 1 | 2014 | 106 | 0.110 |
Why?
|
| Mannosyltransferases | 1 | 2013 | 2 | 0.110 |
Why?
|
| Walker-Warburg Syndrome | 1 | 2013 | 5 | 0.110 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2013 | 7 | 0.110 |
Why?
|
| Multifunctional Enzymes | 1 | 2013 | 5 | 0.110 |
Why?
|
| Middle Aged | 11 | 2020 | 26879 | 0.110 |
Why?
|
| Escherichia coli | 6 | 1990 | 986 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 479 | 0.110 |
Why?
|
| DNA Damage | 1 | 2017 | 513 | 0.110 |
Why?
|
| Nephrolithiasis | 1 | 2013 | 14 | 0.110 |
Why?
|
| Sequence Deletion | 3 | 2012 | 526 | 0.110 |
Why?
|
| Autistic Disorder | 2 | 2014 | 348 | 0.110 |
Why?
|
| Amidinotransferases | 1 | 2013 | 3 | 0.110 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2013 | 7 | 0.110 |
Why?
|
| Thymidine Kinase | 1 | 2013 | 95 | 0.110 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2013 | 64 | 0.110 |
Why?
|
| Guanidinoacetate N-Methyltransferase | 1 | 2013 | 9 | 0.110 |
Why?
|
| Cytosol | 2 | 2016 | 161 | 0.100 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2013 | 22 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 64 | 0.100 |
Why?
|
| Creatine | 1 | 2013 | 41 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2014 | 168 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 101 | 0.100 |
Why?
|
| Speech Disorders | 1 | 2013 | 43 | 0.100 |
Why?
|
| Computational Biology | 2 | 2018 | 810 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2017 | 699 | 0.100 |
Why?
|
| Genome, Mitochondrial | 1 | 2013 | 32 | 0.100 |
Why?
|
| DNA Methylation | 5 | 2022 | 1008 | 0.100 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2004 | 19 | 0.100 |
Why?
|
| Fatal Outcome | 4 | 2011 | 356 | 0.100 |
Why?
|
| Lysosomes | 2 | 2024 | 236 | 0.100 |
Why?
|
| Gene Dosage | 3 | 2013 | 440 | 0.100 |
Why?
|
| Binding Sites | 4 | 2006 | 1295 | 0.100 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2013 | 71 | 0.100 |
Why?
|
| Models, Biological | 2 | 2016 | 1458 | 0.100 |
Why?
|
| Phenylacetates | 1 | 2012 | 23 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2004 | 64 | 0.100 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2009 | 7 | 0.100 |
Why?
|
| Long-Term Care | 1 | 2012 | 69 | 0.100 |
Why?
|
| Spasms, Infantile | 1 | 1994 | 171 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 367 | 0.100 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1991 | 43 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2013 | 339 | 0.090 |
Why?
|
| Chromosome Disorders | 2 | 2010 | 311 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 74 | 0.090 |
Why?
|
| Glucans | 1 | 2011 | 11 | 0.090 |
Why?
|
| Models, Molecular | 4 | 2017 | 1068 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 92 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2017 | 2635 | 0.090 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2011 | 41 | 0.090 |
Why?
|
| GATA4 Transcription Factor | 1 | 2011 | 40 | 0.090 |
Why?
|
| Peptide Chain Termination, Translational | 2 | 1990 | 3 | 0.090 |
Why?
|
| Isochromosomes | 1 | 2011 | 18 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2003 | 2520 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 1112 | 0.090 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2011 | 80 | 0.090 |
Why?
|
| Uniparental Disomy | 1 | 2011 | 49 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2004 | 658 | 0.090 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2011 | 43 | 0.090 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2010 | 3 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2011 | 62 | 0.090 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 2010 | 6 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2018 | 621 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2019 | 1038 | 0.090 |
Why?
|
| DiGeorge Syndrome | 2 | 2004 | 79 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 484 | 0.090 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 252 | 0.090 |
Why?
|
| Organ Specificity | 4 | 2013 | 427 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1991 | 256 | 0.090 |
Why?
|
| Autophagy | 1 | 2014 | 393 | 0.090 |
Why?
|
| Pyridoxine | 1 | 2010 | 14 | 0.090 |
Why?
|
| Gene Targeting | 3 | 2005 | 176 | 0.090 |
Why?
|
| Conserved Sequence | 3 | 2003 | 291 | 0.090 |
Why?
|
| Genetic Linkage | 4 | 2018 | 453 | 0.090 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2010 | 40 | 0.090 |
Why?
|
| Glycolysis | 1 | 2011 | 150 | 0.090 |
Why?
|
| Contractile Proteins | 1 | 2010 | 17 | 0.080 |
Why?
|
| Urea | 2 | 2019 | 226 | 0.080 |
Why?
|
| Bladder Exstrophy | 1 | 2010 | 10 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2010 | 107 | 0.080 |
Why?
|
| Filamins | 1 | 2010 | 25 | 0.080 |
Why?
|
| United States | 3 | 2020 | 10909 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2016 | 78 | 0.080 |
Why?
|
| Electrophysiology | 3 | 2005 | 270 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2011 | 134 | 0.080 |
Why?
|
| Cataract | 1 | 2012 | 222 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 160 | 0.080 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 2 | 2003 | 7 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2014 | 636 | 0.080 |
Why?
|
| Genetic Markers | 5 | 2005 | 604 | 0.080 |
Why?
|
| Protein Domains | 2 | 2023 | 237 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 320 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 131 | 0.080 |
Why?
|
| Insulin | 1 | 2014 | 1201 | 0.080 |
Why?
|
| Synapses | 1 | 2013 | 455 | 0.080 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2009 | 20 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2003 | 4375 | 0.080 |
Why?
|
| Nodal Protein | 1 | 2008 | 16 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 1016 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 150 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2010 | 244 | 0.080 |
Why?
|
| Hepatic Encephalopathy | 1 | 2009 | 75 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2008 | 282 | 0.080 |
Why?
|
| Prognosis | 3 | 2019 | 4631 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2007 | 395 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2008 | 53 | 0.080 |
Why?
|
| Gene Expression | 5 | 2004 | 1562 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2011 | 212 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2008 | 41 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2018 | 383 | 0.070 |
Why?
|
| Actins | 1 | 2010 | 342 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2008 | 62 | 0.070 |
Why?
|
| Protein Transport | 3 | 2016 | 368 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2000 | 286 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 3572 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2010 | 310 | 0.070 |
Why?
|
| Cloning, Molecular | 7 | 2004 | 891 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 274 | 0.070 |
Why?
|
| NAD | 2 | 2005 | 45 | 0.070 |
Why?
|
| Colon | 1 | 2010 | 349 | 0.070 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 13 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 2881 | 0.070 |
Why?
|
| Family Health | 2 | 2006 | 259 | 0.070 |
Why?
|
| RNA Interference | 2 | 2007 | 497 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2018 | 806 | 0.070 |
Why?
|
| Ornithine Carbamoyltransferase | 2 | 2003 | 17 | 0.070 |
Why?
|
| Muridae | 2 | 1997 | 16 | 0.070 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 60 | 0.070 |
Why?
|
| Galactitol | 1 | 2006 | 2 | 0.070 |
Why?
|
| Galactosephosphates | 1 | 2006 | 4 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 173 | 0.070 |
Why?
|
| Facies | 2 | 2021 | 153 | 0.070 |
Why?
|
| Algorithms | 2 | 2012 | 1624 | 0.070 |
Why?
|
| Lactose | 1 | 2006 | 54 | 0.070 |
Why?
|
| Review Literature as Topic | 1 | 2006 | 43 | 0.070 |
Why?
|
| Age of Onset | 4 | 2011 | 590 | 0.060 |
Why?
|
| Glycosylation | 2 | 2018 | 120 | 0.060 |
Why?
|
| Facial Asymmetry | 1 | 2005 | 17 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 208 | 0.060 |
Why?
|
| Motor Activity | 2 | 2006 | 521 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2020 | 4808 | 0.060 |
Why?
|
| Rats | 3 | 2022 | 3676 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2007 | 369 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 1988 | 889 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 793 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2004 | 1327 | 0.060 |
Why?
|
| Choanal Atresia | 1 | 2005 | 18 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2005 | 235 | 0.060 |
Why?
|
| Cyclosporine | 2 | 2003 | 146 | 0.060 |
Why?
|
| Liver | 4 | 2007 | 1737 | 0.060 |
Why?
|
| Texas | 2 | 2017 | 3586 | 0.060 |
Why?
|
| Larva | 1 | 2005 | 244 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 181 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 642 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 1586 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2017 | 1022 | 0.060 |
Why?
|
| Phospholipids | 1 | 2005 | 105 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2004 | 30 | 0.060 |
Why?
|
| Deafness | 1 | 2005 | 82 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2004 | 81 | 0.060 |
Why?
|
| Klebsiella Infections | 1 | 2004 | 54 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 91 | 0.060 |
Why?
|
| Pregnanolone | 1 | 2003 | 11 | 0.060 |
Why?
|
| Neuromuscular Diseases | 1 | 2004 | 56 | 0.060 |
Why?
|
| Oxidation-Reduction | 3 | 2000 | 440 | 0.050 |
Why?
|
| Disease Progression | 2 | 2007 | 2060 | 0.050 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2006 | 309 | 0.050 |
Why?
|
| Transfection | 3 | 2007 | 1062 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2001 | 390 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2018 | 722 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2003 | 59 | 0.050 |
Why?
|
| Haplotypes | 2 | 2017 | 522 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 308 | 0.050 |
Why?
|
| Insect Proteins | 1 | 2004 | 99 | 0.050 |
Why?
|
| DNA Primers | 2 | 2002 | 657 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2023 | 33 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2016 | 245 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2004 | 179 | 0.050 |
Why?
|
| Arginase | 1 | 2003 | 31 | 0.050 |
Why?
|
| p21-Activated Kinases | 1 | 2023 | 57 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1329 | 0.050 |
Why?
|
| Dyneins | 1 | 2002 | 13 | 0.050 |
Why?
|
| Echocardiography | 4 | 2011 | 1052 | 0.050 |
Why?
|
| Steroids | 1 | 2003 | 202 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2003 | 95 | 0.050 |
Why?
|
| Hyperammonemia | 1 | 2003 | 62 | 0.050 |
Why?
|
| Leptin | 1 | 2004 | 214 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2009 | 1392 | 0.050 |
Why?
|
| Gait | 1 | 2023 | 146 | 0.050 |
Why?
|
| X Chromosome Inactivation | 2 | 2014 | 62 | 0.050 |
Why?
|
| Cholesterol | 1 | 2005 | 537 | 0.050 |
Why?
|
| Sexual Behavior, Animal | 1 | 1982 | 87 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2005 | 461 | 0.050 |
Why?
|
| Protein Binding | 3 | 2017 | 1735 | 0.050 |
Why?
|
| Ilium | 1 | 2001 | 23 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2016 | 815 | 0.050 |
Why?
|
| Bone Density | 1 | 2004 | 319 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2022 | 180 | 0.050 |
Why?
|
| Sperm Count | 1 | 2001 | 78 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2001 | 260 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 2902 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2023 | 332 | 0.050 |
Why?
|
| alpha-Glucosidases | 1 | 2021 | 28 | 0.050 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2021 | 17 | 0.050 |
Why?
|
| Segmental Duplications, Genomic | 2 | 2012 | 81 | 0.040 |
Why?
|
| Citrate (si)-Synthase | 1 | 2000 | 17 | 0.040 |
Why?
|
| Physical Conditioning, Animal | 1 | 2002 | 97 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2002 | 277 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1951 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 100 | 0.040 |
Why?
|
| Lymphocytes | 3 | 2017 | 408 | 0.040 |
Why?
|
| Biopsy | 2 | 2001 | 1236 | 0.040 |
Why?
|
| DNA | 4 | 2000 | 1600 | 0.040 |
Why?
|
| Hypertension | 1 | 2009 | 1324 | 0.040 |
Why?
|
| Lactate Dehydrogenases | 1 | 2000 | 2 | 0.040 |
Why?
|
| Aged | 5 | 2020 | 19835 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2021 | 144 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2004 | 622 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 62 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2000 | 202 | 0.040 |
Why?
|
| Lod Score | 1 | 1999 | 120 | 0.040 |
Why?
|
| Pregnancy | 3 | 2021 | 7174 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2019 | 100 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 106 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 225 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 1999 | 32 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2019 | 55 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 282 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2002 | 483 | 0.040 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2000 | 46 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2019 | 16345 | 0.040 |
Why?
|
| Guanosine Diphosphate Fucose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Guanosine Diphosphate Mannose | 1 | 2018 | 3 | 0.040 |
Why?
|
| Adrenal Glands | 2 | 1996 | 43 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1998 | 121 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2018 | 29 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2019 | 152 | 0.040 |
Why?
|
| Time Factors | 3 | 2007 | 6320 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 214 | 0.040 |
Why?
|
| Chorea | 1 | 1999 | 39 | 0.040 |
Why?
|
| Memory | 1 | 2002 | 361 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 315 | 0.040 |
Why?
|
| Ploidies | 1 | 1998 | 37 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 505 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3344 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 555 | 0.040 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 1998 | 6 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 1998 | 146 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 457 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2018 | 141 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2001 | 1885 | 0.040 |
Why?
|
| Tyrosine Transaminase | 1 | 1997 | 12 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 1997 | 7 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 187 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
| Plasmids | 2 | 1997 | 512 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1998 | 62 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 11 | 0.040 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 1997 | 5 | 0.040 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2000 | 150 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 952 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2017 | 26 | 0.040 |
Why?
|
| Connectin | 1 | 2017 | 27 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1691 | 0.040 |
Why?
|
| Hydroxocobalamin | 1 | 2017 | 9 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 330 | 0.040 |
Why?
|
| Nail Diseases | 1 | 1997 | 15 | 0.040 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1997 | 56 | 0.040 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2017 | 59 | 0.040 |
Why?
|
| Poly A | 1 | 1997 | 59 | 0.040 |
Why?
|
| Epidermal Cyst | 1 | 1997 | 19 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 1997 | 36 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2017 | 46 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 77 | 0.030 |
Why?
|
| Cell Death | 2 | 2009 | 240 | 0.030 |
Why?
|
| Cell Survival | 1 | 1999 | 807 | 0.030 |
Why?
|
| Fetal Death | 1 | 1997 | 112 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2010 | 311 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2013 | 830 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1997 | 237 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2016 | 3289 | 0.030 |
Why?
|
| Mitochondrial Swelling | 2 | 2007 | 7 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1991 | 79 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 165 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 143 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 29 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 222 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 238 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 2016 | 20 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 55 | 0.030 |
Why?
|
| Eyelids | 1 | 1997 | 119 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 226 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1996 | 100 | 0.030 |
Why?
|
| Acyl Coenzyme A | 1 | 2016 | 25 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 155 | 0.030 |
Why?
|
| Multigene Family | 1 | 1997 | 298 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1996 | 162 | 0.030 |
Why?
|
| Nucleotides | 1 | 2016 | 92 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2018 | 186 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 124 | 0.030 |
Why?
|
| COS Cells | 1 | 1996 | 275 | 0.030 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 1996 | 12 | 0.030 |
Why?
|
| Isoleucine | 1 | 1996 | 28 | 0.030 |
Why?
|
| RNA | 1 | 1999 | 570 | 0.030 |
Why?
|
| Cytogenetic Analysis | 2 | 2007 | 80 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1997 | 574 | 0.030 |
Why?
|
| Species Specificity | 1 | 1997 | 548 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 93 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 59 | 0.030 |
Why?
|
| Radiography | 1 | 1998 | 821 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2018 | 299 | 0.030 |
Why?
|
| Hyperpigmentation | 1 | 1995 | 12 | 0.030 |
Why?
|
| Fetus | 2 | 2014 | 585 | 0.030 |
Why?
|
| Peripheral Nervous System | 1 | 2015 | 42 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 2011 | 119 | 0.030 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 1996 | 77 | 0.030 |
Why?
|
| Genetic Carrier Screening | 1 | 2015 | 68 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2018 | 319 | 0.030 |
Why?
|
| Adrenal Insufficiency | 1 | 1995 | 28 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1996 | 154 | 0.030 |
Why?
|
| Carnitine | 1 | 2015 | 74 | 0.030 |
Why?
|
| Aging | 1 | 1982 | 1183 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6588 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 123 | 0.030 |
Why?
|
| Permeability | 2 | 2009 | 122 | 0.030 |
Why?
|
| Microinjections | 2 | 1991 | 52 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2004 | 2385 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1996 | 337 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2018 | 695 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 1994 | 28 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 384 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 417 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1230 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 354 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2014 | 127 | 0.030 |
Why?
|
| Phylogeny | 1 | 1996 | 696 | 0.030 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 27 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1994 | 100 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 1994 | 90 | 0.030 |
Why?
|
| Methylmalonic Acid | 1 | 2013 | 15 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2013 | 22 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2015 | 253 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 541 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2013 | 26 | 0.030 |
Why?
|
| Software | 1 | 2018 | 683 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2015 | 190 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1994 | 45 | 0.030 |
Why?
|
| Dystroglycans | 1 | 2013 | 4 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 126 | 0.030 |
Why?
|
| Coma | 1 | 1994 | 55 | 0.030 |
Why?
|
| Ammonia | 1 | 1994 | 75 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 236 | 0.030 |
Why?
|
| Blindness | 1 | 1994 | 72 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2013 | 63 | 0.030 |
Why?
|
| Infant, Premature | 1 | 1999 | 818 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3729 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 354 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 107 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 223 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 66 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12405 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2011 | 975 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2012 | 8 | 0.030 |
Why?
|
| Organ Size | 2 | 2005 | 431 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2012 | 21 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 16 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 646 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2017 | 865 | 0.020 |
Why?
|
| GRB10 Adaptor Protein | 2 | 2003 | 5 | 0.020 |
Why?
|
| Dioxins | 1 | 1991 | 3 | 0.020 |
Why?
|
| PubMed | 1 | 2012 | 20 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 656 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1311 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 211 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 125 | 0.020 |
Why?
|
| Thymidine Phosphorylase | 1 | 2011 | 12 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 176 | 0.020 |
Why?
|
| DNA Polymerase gamma | 1 | 2011 | 10 | 0.020 |
Why?
|
| Dystrophin | 1 | 2011 | 37 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 70 | 0.020 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2012 | 84 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 79 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 219 | 0.020 |
Why?
|
| Cerebral Ventricles | 2 | 2004 | 81 | 0.020 |
Why?
|
| Creatinine | 1 | 2013 | 390 | 0.020 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2011 | 40 | 0.020 |
Why?
|
| Hospitalization | 1 | 2019 | 1780 | 0.020 |
Why?
|
| Heart Failure | 1 | 2004 | 2285 | 0.020 |
Why?
|
| Ear, Middle | 1 | 2011 | 25 | 0.020 |
Why?
|
| Liposomes | 2 | 2004 | 178 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 541 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2011 | 49 | 0.020 |
Why?
|
| Ornithine Decarboxylase | 1 | 1990 | 18 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2011 | 62 | 0.020 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2010 | 1 | 0.020 |
Why?
|
| Peristalsis | 1 | 2010 | 8 | 0.020 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 1990 | 2 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 133 | 0.020 |
Why?
|
| Oxo-Acid-Lyases | 1 | 1990 | 3 | 0.020 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 118 | 0.020 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 1990 | 26 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Chromosomes | 1 | 2010 | 199 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 135 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2009 | 7 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 1994 | 596 | 0.020 |
Why?
|
| Placenta | 1 | 2013 | 507 | 0.020 |
Why?
|
| Recurrence | 2 | 2003 | 1421 | 0.020 |
Why?
|
| NIMA-Related Kinase 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 51 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2009 | 257 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2008 | 49 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2008 | 55 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 355 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 2003 | 812 | 0.020 |
Why?
|
| Education, Medical | 1 | 2012 | 288 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1093 | 0.020 |
Why?
|
| DNA, Bacterial | 2 | 1988 | 477 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2051 | 0.020 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 51 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 712 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6155 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1986 | 56 | 0.020 |
Why?
|
| Dibenzocycloheptenes | 1 | 2006 | 2 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2006 | 4 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2006 | 4 | 0.020 |
Why?
|
| Ethylmaleimide | 1 | 2006 | 13 | 0.020 |
Why?
|
| Caspases | 1 | 2007 | 162 | 0.020 |
Why?
|
| Arsenicals | 1 | 2006 | 14 | 0.020 |
Why?
|
| Spiro Compounds | 1 | 2006 | 13 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2006 | 25 | 0.020 |
Why?
|
| Gestational Age | 1 | 2010 | 1160 | 0.020 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2005 | 5 | 0.020 |
Why?
|
| Rett Syndrome | 1 | 2009 | 291 | 0.020 |
Why?
|
| Porosity | 1 | 2005 | 38 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2005 | 88 | 0.020 |
Why?
|
| Feedback | 1 | 1986 | 164 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 660 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 1613 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2004 | 22 | 0.010 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2004 | 8 | 0.010 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2005 | 122 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 92 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 81 | 0.010 |
Why?
|
| Cyclin T | 1 | 2004 | 34 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 970 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 781 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1987 | 429 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 2004 | 100 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 101 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2004 | 100 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2004 | 72 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 2003 | 8 | 0.010 |
Why?
|
| Aziridines | 1 | 2003 | 11 | 0.010 |
Why?
|
| Photochemistry | 1 | 2003 | 22 | 0.010 |
Why?
|
| Lipodystrophy | 1 | 2004 | 33 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 69 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2003 | 44 | 0.010 |
Why?
|
| Staurosporine | 1 | 2003 | 23 | 0.010 |
Why?
|
| Biopolymers | 1 | 2003 | 20 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2003 | 39 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 710 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 78 | 0.010 |
Why?
|
| Systole | 1 | 2003 | 199 | 0.010 |
Why?
|
| Synapsins | 1 | 2003 | 6 | 0.010 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2003 | 112 | 0.010 |
Why?
|
| Anions | 1 | 2003 | 18 | 0.010 |
Why?
|
| Etoposide | 1 | 2003 | 114 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 215 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 579 | 0.010 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 2 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2003 | 125 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2002 | 29 | 0.010 |
Why?
|
| Axonemal Dyneins | 1 | 2002 | 1 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 98 | 0.010 |
Why?
|
| Ejaculation | 1 | 1982 | 20 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 221 | 0.010 |
Why?
|
| Corticosterone | 1 | 1982 | 58 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2002 | 158 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 226 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 805 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 759 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2003 | 443 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 488 | 0.010 |
Why?
|
| Anesthesia | 1 | 2003 | 210 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 799 | 0.010 |
Why?
|
| Procollagen | 1 | 2000 | 13 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 79 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 544 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1990 | 187 | 0.010 |
Why?
|
| Homeostasis | 1 | 2004 | 700 | 0.010 |
Why?
|
| Yeasts | 1 | 1999 | 42 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 1999 | 46 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 605 | 0.010 |
Why?
|
| Fathers | 1 | 2000 | 68 | 0.010 |
Why?
|
| Ependyma | 1 | 1999 | 7 | 0.010 |
Why?
|
| Vision, Low | 1 | 1999 | 14 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2060 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 239 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 2154 | 0.010 |
Why?
|
| Cysts | 1 | 1999 | 101 | 0.010 |
Why?
|
| Endoglin | 1 | 1998 | 21 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1705 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1997 | 27 | 0.010 |
Why?
|
| Viscera | 1 | 1997 | 55 | 0.010 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 1996 | 8 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 1288 | 0.010 |
Why?
|
| Mothers | 1 | 2000 | 354 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 279 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 4496 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1998 | 422 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 469 | 0.010 |
Why?
|
| Epidermis | 1 | 1995 | 63 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1993 | 30 | 0.010 |
Why?
|
| Hypogonadism | 1 | 1996 | 284 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 10285 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 2096 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1990 | 3 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1990 | 41 | 0.010 |
Why?
|
| Valerates | 1 | 1990 | 9 | 0.010 |
Why?
|
| Dicarboxylic Acids | 1 | 1990 | 34 | 0.010 |
Why?
|
| Gene Library | 1 | 1990 | 217 | 0.010 |
Why?
|
| Rabbits | 1 | 1990 | 710 | 0.000 |
Why?
|
| Leucine | 1 | 1990 | 311 | 0.000 |
Why?
|
| Chromosomes, Bacterial | 1 | 1988 | 64 | 0.000 |
Why?
|
| Oocytes | 1 | 1990 | 295 | 0.000 |
Why?
|
| Genes, Bacterial | 1 | 1988 | 209 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1990 | 767 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 120 | 0.000 |
Why?
|
| Acetyltransferases | 1 | 1986 | 90 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1990 | 776 | 0.000 |
Why?
|